good company - Mitarbeiter (anonym) bei Sanofi: Mitarbeiterbewertung

4,0
10. Juli 2013
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good r&d processes with an emphasis on science HR is getting better - becoming more employee focused They have a promising pipeline

Kontras

Very top heavy structure. Decisions are often slow, diluted and poorly communicated. Progression not always possible Most major pharma companies acquiring vaccines - there is incresing competition

Mehr Bewertungen zu Sanofi entdecken

5,0
24. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

work life balance, benefits, flexibility

Kontras

less competitive salary, less promotion

3,0
1. Juli 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Extensive and active employee resource groups, strong leadership development opportunities, clear company mission, gig opportunities that support career development, strong employee support through the ombuds office and compliance help line, and stable company portfolio.

Kontras

No work-life balance considerations with hybrid work model, contradictions in company mission compared to policies (i.e., target to reduce carbon emissions with employee commuting to office as one of the top 5 causes but yet still requiring employees to commute to office 3 days a week), some office sites are not conducive to in office productivity (not enough privacy or space), compensation package is not competitive for MA pharmaceutical companies, long-term incentives have almost no value once they are vested, health care benefits require employees to jump through hoops to maximize discounts or qualify for coverage of certain medications, and accountability for department leadership to follow the corporate leadership pillars is inconsistent across departments.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle